Skip to main content
Krka
  • About us
  • Products
  • Health matters
  • Investors
  • Media center
  • Employment
EN

Choose a country

Krka around the world

For Healthcare Professionals

Access extended content about our products and healthcare studies.

Login

Do you want to logout?


Logout
  • About us
  • Products
  • Health matters
  • Investors
  • Media center
  • Employment
  • About us
  • Krka at a glance
  • Management
  • International presence
  • Sustainability (ESG)
  • Products
  • Therapeutic areas
  • Clinically proven
  • Science and technology
  • Quality
  • Our products
  • Health matters
  • Articles
  • Podcasts
  • Investors
  • Financial reports
  • Share trading
  • Financial calendar
  • Shareholder structure
  • Corporate governance
  • Investor information
  • Benefits of owning Krka shares
  • Media center
  • News
  • Multimedia center
  • Employment
  • Join us
  • Why work at Krka?
  • Areas of work
  • Employees share their stories
  • Krka at a glance
  • Our mission, vision and values
  • Development strategy
  • Areas of operation
  • History
  • Identity card
  • Management
  • Management board
  • Supervisory board
  • Sustainability (ESG)
  • Environment
  • Social
  • Governance
  • Krka ESG Rating
  • Therapeutic areas
  • Cardiovascular diseases
  • Gastrointestinal disorders
  • Central nervous system diseases
  • Pain
  • Diabetes
  • Cough and cold
  • Parasites in dogs and cats
  • Science and technology
  • State-of-the-art technology
  • Achievements
  • Quality
  • Ensuring quality
  • Dedicated to quality
  • Quality management
  • Investor information
  • Corporate releases
  • Investor conferences
  • About Krka shares
  • Dividends
  • Documents
  • Frequently asked questions
  • Areas of work
  • Marketing
  • Sales
  • Corporate performance management
  • Regulatory affairs and pharmacovigilance
  • Production
  • Quality management
  • Engineering and technical services
  • Research and development
  • Supply chain
  • Information technology
  • Environment
  • Strategy and environmental policy
  • Energy and natural resources
  • Environmental impact
  • Social
  • Product quality and patient safety
  • Talent attraction and retention
  • Accessible healthcare
  • Social responsibility
  • Governance
  • Good leadership and governance practices
  • Compliance, integrity and transparency
  • State-of-the-art technology
  • Development and production of APIs
  • Development of pharmaceutical products
  • Analytical techniques and research
  • Production of finished products
  • Achievements
  • Bilayer tablets
  • Prolonged-release tablets
  • Osmotic-controlled release innovation
  • Ensuring quality
  • Development and production of APIs
  • Provision of raw materials
  • Development and production of pharmaceutical forms
  • Quality assurance
  • Finished product approval
  • Product distribution
  • Dispensing of medicines and their use
  • About Krka shares
  • Share split
  • Dividends
  • Dividends paid
  • Documents
  • Annual General Meeting
  • Corporate governance documents
  • Disclaimer
  • Information memorandum
  • Social responsibility
  • Partnership
  • Dedicated to sport
  • Dedicated to culture
  • Dedicated to science
  • Supporting healthcare institutions
  • Charity and volunteering
  • Good leadership and governance practices
  • Personal data protection
  • Compliance, integrity and transparency
  • Integrity and compliance
  • Krka’s Code of conduct
  • Chief Compliance Officer
  • Transparency and reporting
FONT
SIZE
- 0 +
LOWER/UPPERCASE
Lower UPPER
STYLE
Normal Bold
THEME
  • None
  • Black
    White
  • Show
    images
  • Hide
    Images
Reset Close
HomeProductsZdravila na recept

Zdravila na recept

Iščite po izdelku ali učinkovini

  • A
  • B
  • C
  • Č
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • Š
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • Ž

ZA STROKOVNO JAVNOST

Dostopajte do razširjenih vsebin o izdelkih.

Prijava 

Prijava neželenih učinkov

Če želite prijaviti neželene učinke, nam pošljite izpolnjeni obrazec za prijavo neželenih učinkov.

Obrazec
 

Entry points

Healthcare professionals Patients Investors Media Job seekers

Contact us

Contact

Krka, d. d., Novo mesto
Šmarješka cesta 6
8501 Novo mesto
Slovenia

Phone: (+386) 7 331 21 11
Fax: (+386) 7 332 15 37
Email: info@krka.biz

Krka around the world

Follow us

 

Visit our webpages: Terme Krka Krka websites


Legal notice Cookies Personal data protection Entry for partners Map

All rights reserved. Krka, tovarna zdravil, d. d., Novo mesto